Genmab Ownership | Who Owns Genmab?
Genmab Ownership Summary
Genmab is owned by 21.72% institutional investors, and 78.27% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of GMAB shares. iShares Biotechnology ETF is the top mutual fund, with 0.70% of its assets in Genmab shares.
GMAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genmab | 21.72% | - | 78.27% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 5.08M | 7.78% | $127.67M |
| Paradigm biocapital advisors lp | 13.13M | 2.14% | $360.77M |
| Orbis allan gray | 11.37M | 1.85% | $312.28M |
| Alliancebernstein | 8.64M | 1.41% | $231.94M |
| Deerfield management company, l.p. (series c) | 6.87M | 1.12% | $188.58M |
| Arrowstreet capital, limited partnership | 6.07M | 0.99% | $216.52M |
| Blackrock funding, inc. /de | 6.06M | 0.99% | $216.09M |
| Deep track capital, lp | 5.65M | 0.92% | $155.21M |
| Sofinnova investments | 4.05M | 0.66% | $111.12M |
| Capital world investors | 3.90M | 0.64% | $139.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Superstring capital management lp | 430.60K | 7.47% | $11.83M |
| Paradigm biocapital advisors lp | 13.13M | 6.76% | $360.77M |
| Sofinnova investments | 4.05M | 5.74% | $111.12M |
| Ikarian capital | 175.00K | 5.35% | $53.02M |
| Deep track capital, lp | 5.65M | 2.26% | $155.21M |
| Highvista strategies | 226.10K | 2.12% | $8.07M |
| Deerfield management company, l.p. (series c) | 6.87M | 1.97% | $188.58M |
| Terra nova asset management | 68.53K | 1.57% | $2.44M |
| Aimz investment advisors | 160.56K | 1.52% | $5.73M |
| Lionhunter capital management | 83.00K | 1.32% | $2.96M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 13.13M | 6.76% | 5.17M |
| Deerfield management company, l.p. (series c) | 6.87M | 1.97% | 4.40M |
| Capital world investors | 3.90M | 0.02% | 3.90M |
| Sofinnova investments | 4.05M | 5.74% | 3.29M |
| Citadel advisors | 2.48M | 0.01% | 2.48M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -2.57M |
| Wellington management group llp | - | - | -2.31M |
| Orbis allan gray | 11.37M | 1.07% | -1.56M |
| Qube research | 426.93K | 0.01% | -1.26M |
| Renaissance | 2.27M | 0.11% | -1.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Capital world investors | 3.90M | 0.02% | 3.90M | $139.16M |
| Highvista strategies | 226.10K | 2.12% | 226.10K | $8.07M |
| Caption management | 199.77K | 0.03% | 199.77K | $5.49M |
| Capital sarl | 180.67K | 0.09% | 180.67K | $6.45M |
| Ikarian capital | 175.00K | 5.35% | 175.00K | $53.02M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
| Deutsche bank ag\ | -4.00 |
| Bear mountain capital | -6.00 |
| Asset dedication | -7.00 |
| Mendota financial group | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 355 | 15.64% | 133,249,906 | 30.10% | 21 | 7.79% | 204 | 34.21% | 86 | -16.50% |
| Jun 30, 2026 | 303 | 8.60% | 102,423,616 | 25.15% | 16 | 9.46% | 151 | 0.67% | 101 | 6.32% |
| Mar 31, 2026 | 146 | -50.34% | 8,396,925 | -88.53% | 1 | 0.96% | 74 | -63.00% | 48 | -5.88% |
| Dec 31, 2025 | 222 | -12.60% | 29,400,140 | -52.44% | 4 | 4.76% | 148 | -10.84% | 38 | -37.70% |
| Sep 30, 2025 | 179 | -15.96% | 28,573,191 | -37.70% | 4 | 0.09% | 120 | 5.26% | 40 | -44.44% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Biotechnology ETF | 4.31M | 0.70% | -14.85K |
| AllianceBernstein US L/C Growth Eqty MF | 3.95M | 0.64% | - |
| American Funds New Perspective A | 3.08M | 0.50% | 3.08M |
| First Trust NYSE Arca Biotech ETF | 2.64M | 0.43% | - |
| Vanguard Health Care Inv | 2.29M | 0.36% | - |
| Orbis SICAV Intl Eq Inv | 2.21M | 0.36% | -779.34K |
| Pictet-Biotech P USD | 2.08M | 0.34% | 1.37M |
| T. Rowe Price International Gr Eq SMA | 1.90M | 0.30% | 1.90M |
| Orbis SICAV Global Bal Instl Inv | 1.79M | 0.29% | - |
| AB Large Cap Growth A | 1.69M | 0.27% | -156.45K |
GMAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools